Ignite Creation Date:
2025-12-25 @ 3:03 AM
Ignite Modification Date:
2026-01-21 @ 6:37 AM
Study NCT ID:
NCT05535933
Status:
RECRUITING
Last Update Posted:
2025-03-17
First Post:
2022-08-31
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
HMPL-523 (Sovleplenib) in the Treatment of Warm Antibody Autoimmune Hemolytic Anemia
Sponsor:
Hutchison Medipharma Limited
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-09-30
Start Date Type:
ACTUAL
Primary Completion Date:
2026-09
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-11
Completion Date Type:
ESTIMATED
First Submit Date:
2022-08-31
First Submit QC Date:
None
Study First Post Date:
2022-09-10
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-03-13
Last Update Post Date:
2025-03-17
Last Update Post Date Type:
ACTUAL